Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs
Publication
, Conference
Shelton, RC; Pencina, MJ; Barrentine, LJ; Ruiz, JA; Papakostas, GI; Zajecka, ZM; Fava, M
Published in: BIOLOGICAL PSYCHIATRY
May 1, 2015
Duke Scholars
Published In
BIOLOGICAL PSYCHIATRY
EISSN
1873-2402
ISSN
0006-3223
Publication Date
May 1, 2015
Volume
77
Issue
9
Start / End Page
131S / 131S
Location
Toronto, CANADA
Publisher
ELSEVIER SCIENCE INC
Conference Name
70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology
Related Subject Headings
- Psychiatry
- 52 Psychology
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shelton, R. C., Pencina, M. J., Barrentine, L. J., Ruiz, J. A., Papakostas, G. I., Zajecka, Z. M., & Fava, M. (2015). Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs. In BIOLOGICAL PSYCHIATRY (Vol. 77, pp. 131S-131S). Toronto, CANADA: ELSEVIER SCIENCE INC.
Shelton, Richard C., Michael J. Pencina, Lori J. Barrentine, Juan A. Ruiz, George I. Papakostas, Zajecka M. Zajecka, and Maurizio Fava. “Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs.” In BIOLOGICAL PSYCHIATRY, 77:131S-131S. ELSEVIER SCIENCE INC, 2015.
Shelton RC, Pencina MJ, Barrentine LJ, Ruiz JA, Papakostas GI, Zajecka ZM, et al. Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs. In: BIOLOGICAL PSYCHIATRY. ELSEVIER SCIENCE INC; 2015. p. 131S-131S.
Shelton, Richard C., et al. “Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs.” BIOLOGICAL PSYCHIATRY, vol. 77, no. 9, ELSEVIER SCIENCE INC, 2015, pp. 131S-131S.
Shelton RC, Pencina MJ, Barrentine LJ, Ruiz JA, Papakostas GI, Zajecka ZM, Fava M. Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs. BIOLOGICAL PSYCHIATRY. ELSEVIER SCIENCE INC; 2015. p. 131S-131S.
Published In
BIOLOGICAL PSYCHIATRY
EISSN
1873-2402
ISSN
0006-3223
Publication Date
May 1, 2015
Volume
77
Issue
9
Start / End Page
131S / 131S
Location
Toronto, CANADA
Publisher
ELSEVIER SCIENCE INC
Conference Name
70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology
Related Subject Headings
- Psychiatry
- 52 Psychology
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences